STK11 and cancer: Recent studies found that STK11 mutation exposed cancer cells to metabolic crisis and apoptosis, and sensitized those cells to the antidiabetic compounds (Shackelford et al., 2013), which lower intracellular ATP levels by inhibiting mitochondrial oxidative phosphorylation.